Pravastatin sodium NDC 55111-230

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-230Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0230Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-230-01	55111023001	100 TABLET in 1 BOTTLE (55111-230-01)Marketed from Dec 31, 2009
55111-230-05	55111023005	500 TABLET in 1 BOTTLE (55111-230-05)Marketed from Dec 31, 2009
55111-230-30	55111023030	30 TABLET in 1 BOTTLE (55111-230-30)Marketed from Dec 31, 2009
55111-230-90	55111023090	90 TABLET in 1 BOTTLE (55111-230-90)Marketed from Dec 31, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pravastatin sodium
Generic name (nonproprietary): pravastatin sodium
Active ingredients: Pravastatin sodium — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dr.Reddy's Laboratories Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076714
Marketing start: Dec 31, 2009
Listing expires: Dec 31, 2026
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 55111-230_5f4e21ff-4bcc-df0d-a629-ba190d95edc0SPL ID 5f4e21ff-4bcc-df0d-a629-ba190d95edc0SPL set ID 99cc0546-bb2d-751e-edfd-1c15a1182e0cRxCUI 904458, 904467, 904475, 904481UNII 3M8608UQ61
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111023001 followed by a unit qualifier and the quantity

Package 55111-0230-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 21, 2018.

Indications (excerpt from the label)

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. Pravastatin sodium is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce the risk of MI,revascularization, andcardiovascularmortalityin hypercholesterolemicpatientswithout clinicallyevidentCHD. (1.1) Reduce the risk of total mortality by reducing coronary deat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076714

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076714
Product	Strength	Form · route	Labeler	Product NDC
Pravastatin sodium	Pravastatin sodium 10 mg/1	TabletOral	Dr.Reddy's Laboratories Limited	55111-229
Pravastatin sodium	Pravastatin sodium 40 mg/1	TabletOral	Dr.Reddy's Laboratories Limited	55111-231
Pravastatin sodium	Pravastatin sodium 80 mg/1	TabletOral	Dr.Reddy's Laboratories Limited	55111-274